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Center for Systems and Synthetic Biology and Department of Biochemistry and Biophysics, University of California, San Francisco, CaliforniaABSTRACT Organelles serve as biochemical reactors in the cell, and often display characteristic scaling trends with cell size,
suggesting mechanisms that coordinate their sizes. In this study, we measure the vacuole-cell size scaling trends in budding
yeast using optical microscopy and a novel, to our knowledge, image analysis algorithm. Vacuole volume and surface area
both show characteristic scaling trends with respect to cell size that are consistent among different strains. Rapamycin treatment
was found to increase vacuole-cell size scaling trends for both volume and surface area. Unexpectedly, these increases did not
depend on macroautophagy, as similar increases in vacuole size were observed in the autophagy deficient mutants atg1D and
atg5D. Rather, rapamycin appears to act on vacuole size by inhibiting retrograde membrane trafficking, as the atg18D mutant,
which is defective in retrograde trafficking, shows similar vacuole size scaling to rapamycin-treated cells and is itself insensitive
to rapamycin treatment. Disruption of anterograde membrane trafficking in the apl5Dmutant leads to complementary changes in
vacuole size scaling. These quantitative results lead to a simple model for vacuole size scaling based on proportionality between
cell growth rates and vacuole growth rates.INTRODUCTIONOrganelles play critical roles in cell physiology by acting as
reaction vessels for biochemical reactions. Eukaryotic cells
are able to develop complex, overlapping metabolic path-
ways by using organelles to compartmentalize biochemical
reactions and to optimize the environment needed for those
reactions. For example, the internal redox state of the endo-
plasmic reticulum is tuned to promote proper protein fold-
ing, and degradative organelles like the vacuole/lysosome
maintain an acidic pH necessary for catabolic processes to
proceed efficiently. Because of the functional importance
of organelles, it is perhaps not surprising that organelle
size is responsive to various stresses or cell states (1).
Furthermore, it has been widely observed that as cells
grow larger, their organelles also increase in size, i.e., organ-
elle size scales with cell size (2–4) rather than maintain a
constant absolute size. At a basic level, it is intuitive to think
that as the cell grows, functional demand for its organelles
increase, and therefore organelles grow to meet that in-
creased demand. During cell division, organelles also need
to increase in size such that enough can be provided to
each daughter cell, as they generally proliferate via expan-
sion and budding of existing organelles as opposed to
de novo formation. There are thus strong a priori reasons
to expect a positive scaling correlation between organelle
size and cell size that would cause organelles to become
larger as cells grow. Indeed, such scaling behavior has
been observed for a wide variety of organelles, including
the nucleus (3,5,6), mitochondria (7), and vacuole/lysosome
(8,9). Although basic observations of organelle size scalingSubmitted November 18, 2013, and accepted for publication March 6, 2014.
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0006-3495/14/05/1986/11 $2.00suggest active regulation of organelle size in response to
cellular growth, very little is known about the nature of these
scaling relationships or the mechanisms by which they are
achieved.
The yeast vacuole presents an interesting model for
organelle size scaling, as it carries out essential biochemical
functions both in its lumen (degradation, storage) and at the
limiting membrane (signaling). Therefore, the cell is likely
to control both the organelle’s internal volume and surface
area. Individual cells typically have 1–10 vacuoles that
tend to be clustered (Fig. 1 A). Unlike other organelles
such as the mitochondria that have a characteristic mor-
phology that constrains the relationship between surface
area and volume, yeast vacuoles can exhibit a range of
morphologies. Consequently, the vacuole can adopt a wide
range of volume to surface area ratios (10). Thus, the
vacuole is an ideal model for determining how a single
organelle’s volume and surface area are controlled in either
an independent or coordinated fashion as well as how this
relates to cell size.
Previous genetic screens have identified a great number of
vacuole morphology mutants (11–14), but were unlikely to
identify genes involved in vacuole-to-cell size scaling for
two reasons. First, these screens typically relied on gross
morphological criteria to categorize the mutants by visual
inspection. Without a quantitative measure of vacuole
size, it is not possible to detect more subtle variations. Sec-
ond, because we suspect a priori that vacuole size may be
correlated with cell size, any mutation affecting cell size
would also exhibit an altered absolute vacuole size without
necessarily affecting vacuole size control pathways per se.
Only a change in vacuole-to-cell size scaling would strongly
indicate some perturbation to vacuole size control. It is
thus essential to measure vacuole size quantitatively inhttp://dx.doi.org/10.1016/j.bpj.2014.03.014
FIGURE 1 Vacuole size extraction and vacuole
size scaling in WT strains. (A) Cells (brightfield)
and vacuoles (VPH1-GFP) were imaged using a
spinning disk confocal microscope. (B) Z-stacks
were processed using a computational algorithm
to reconstruct surfaces for each vacuole. (C) Cell
and vacuole sizes measurements were fit with
power-law scaling trends, which can be compared
between different mutants and conditions. (D) Vac-
uole volume-cell volume scaling and (E) Vacuole
surface area-cell volume scaling trends for
W303A and BY4741 background strains.
Organelle Size Scaling 1987comparison with cell size if we are to begin a molecular
dissection of the mechanisms of organelle scaling. To
date, quantitative studies on organelle size have been
limited due to the difficulty in extracting measurements of
size on subcellular size scales. Thus, the precise scaling
relationship between vacuole and cell size remains an
open question.
We present here a novel, to our knowledge, method for
measuring the size of objects on the size scale of the vacuole
(Fig. 1, A–C). Using this method, we found that vacuole
volume and surface area show distinct scaling trends with
respect to cell size, and have found evidence for a molecular
pathway, which contributes to establishing these scaling
trends by adjusting the balance of membrane traffic to and
from the vacuole.MATERIALS AND METHODS
Yeast strains and culture
BY4741 VPH1-GFP was taken from the yeast GFP insertion library.
atg18D, apl5D, BYatg1D, and BYatg5D deletion mutant strains were ob-
tained from the yeast deletion library. These strains and the W303A wild-
type (WT) strains were transformed with VPH1-GFP at the chromosomal
locus using the HIS3 selection marker. Autophagy deletion mutants
atg1D and atg5D in the W303A background with integrated VPH1-GFP
were kindly provided by the Walter lab (UCSF). A full strain list is shown
in Table S1 in the Supporting Material.
Cells were grown overnight in liquid YPAD media at 30C, and then
inoculated into fresh YPAD and allowed to grow through at least two dou-
blings to reach OD 0.3. For log-growth measurements, cells were allowed to
continue growing until they reached OD 0.6. For rapamycin-treated cells,
an aliquot of culture was taken at OD 0.3, and then rapamycin from a
1000 DMSO stock was added to a final concentration of 0.2 mg/mL. Cellswere incubated at 30C for an additional 4 h and typically doubled in OD
during this time.Imaging
Cells were mounted onto glass coverslips treated with Concanavelin A.
Imaging was performed at room temperature using a Nikon-Ti Eclipse
microscope equipped with a Hamamatsu Spinning Disk Head for optical
sectioning. A 100 objective (NA ¼ 1.49 PlanApo TIRF) and 1.5 optivar
was used. 10 mm image stacks centered roughly at the cell equator were
acquired using a 0.2 mm nominal z-spacing in brightfield (cell outline)
and in fluorescence using a 491 nm diode laser for excitation (VPH1-
GFP in the vacuole membrane).Image analysis
Fluorescence images of vacuoles were visually scanned in ImageJ to deter-
mine and record center point coordinates for each individual vacuole. Data
were then exported to MATLAB (The MathWorks, Natick, MA) for seg-
mentation using the algorithm described in the Results section. Image
stacks were resampled to equalize voxel dimensions. Intensity profiles
along individual rays were calculated using linear interpolation of voxel in-
tensities. A shallow weighting function of the form 1/(1þi/N)—where i is
the distance along the ray and N is the total ray length—was applied to in-
tensity profiles to bias the algorithm to select the nearest of multiple
crossing points. Shape fitting was performed by least squares fitting using
a linear combination of basis functions generated according to (15). These
functions were defined as products of simple trigonometric functions in
radial coordinates, and arbitrarily good surface fits can be obtained by
generating large numbers of basis functions. In this study, the number of
basis functions was limited to 18 to provide a balance between typical vac-
uole shape complexity and overfitting of noisy surfaces. Volume and sur-
face area measurements were performed using the MATLAB program
MyRobustCrust, which is available online. For cell volume measurements,
brightfield stacks were scanned manually to find a consistent z-slice with
respect to the cell equator. The cell outline in this plane was traced manuallyBiophysical Journal 106(9) 1986–1996
1988 Chan and Marshalland fit to an ellipse (5,7). Cell volume was calculated assuming an oblate
spheroid shape. Mother and buds were treated separately to allow for sep-
aration of total cell into the two compartments.Scaling analysis
Scaling parameters were calculated using raw data (see Fig. 1 C) after trans-
forming into log-log axes. Regression line analysis of log-log plots gave a
slope (m) with a standard error (sm), which was used as equivalent to the
scaling exponent, a, and its standard error. Values for a in the text are there-
fore reported asm5 sm. To validate this analysis, bootstrap resampling was
performed on the log-log scatter plots to create 10,000 data sets with the
same n as the original experiments. Resampling confirmed the mean values
for m and gave 95% confidence interval errors ranging from 1 to 1.5 sm.RESULTS
Vacuole size measurement algorithm
To understand vacuole size scaling, a key requirement is to
be able to measure vacuole size precisely to ask how vacuole
size may change as a function of cell size or genetic pertur-
bations. We thus implemented a novel, to our knowledge,
computational method to extract vacuole size measurements
from optical images (8). The method entails five steps as fol-
lows (an example of segmented vacuole is given in Fig. 1 B):
1. Data acquisition: First, three-dimensional z-stacks are
taken on a spinning disk confocal microscope through
vacuoles that are fluorescently labeled at the limiting
membrane with the fusion protein VPH1-GFP. Details
of imaging conditions are given in the Materials and
Methods.
2. Center point identification: Vacuoles typically exist as a
clustered group of membrane-bound compartments. The
images are scanned manually to identify a point(s)
roughly at the center(s) of each individual vacuole
compartment. This method is tolerant of minor errors
in this step, as center point selection can vary by a few
pixels without producing highly different volume or sur-
face area measurements.
3. Ray drawing: For every vacuole center point, a number
of rays (typically 500) are computationally constructed
starting at the center point and radiating outward. The
angular distribution of these rays is chosen to give a
roughly constant density of rays over a spherical surface.
The fluorescence intensity profile is interpolated at
equally spaced points along each ray. Because the vacu-
oles are membrane labeled, the point of maximal inten-
sity should be located where the ray crosses the
membrane. The coordinates of the crossing points of
every ray are collected to give a point cloud that defines
the vacuole surface.
4. Surface fitting: Volume and surface area are then deter-
mined by fitting a mathematically defined surface to
the point cloud, from which geometric parameters can
be directly computed. A variety of surface representa-
tions can be used to fit the resulting point cloud. ForBiophysical Journal 106(9) 1986–1996instance, a triangle mesh can be constructed to connect
nearest neighbor points, which would tend to overesti-
mate the surface area of objects as there is some noise
in the point cloud coordinates. A surface can also be fit
using a priori knowledge of the shape of the object,
such as using a prolate spheroid to fit yeast cells. How-
ever, though the vacuole compartments often seem to
be spherical by eye, roughly 5% of vacuole compart-
ments show sphericity <0.9. We therefore use a more
general surface fitting method (15) rather than assuming
a perfect sphere. In this method, a function generator
defines a set of basis functions, and these are used to
find a best-fit surface to the point cloud. The number of
basis functions is constrained to prevent overfitting,
which results in an overall smoothing of the point cloud.
This method is able to address almost all of the vacuole
morphologies observed to date. An example is given
in Fig. 1.
5. Validation: The method was tested on two sets of spher-
ical beads 0.96 mm (n¼ 101) and 2 mm (n¼ 38) in diam-
eter. Averages of measured volumes and surface areas all
came within 10% of expected values. The method was
also tested on computationally generated ellipsoidal sur-
faces ranging from 0.8 to 2.0 mm in diameter, and again,
measurements came within 10% of expected values.
Larabell et al. (9) have used soft x-ray tomography to
measure yeast cell and organelle size (strain DDY904).
Our measurements of average cell and vacuole size in
the W303A strain were generally larger, but values for
BY4741 fell within reported size ranges (see Table S2),
showing that the cell outline tracing and vacuole surface
reconstruction methods give similar size distributions
to reported values. The discrepancies in absolute size
measurements may be reflective of differences in
strains. On the other hand, the vacuole-to-cell volume
ratios in W303A and BY4741 were 10 5 0.2% and
7 5 0.2%, respectively, both of which fall within the
range of 3–14% reported for strain DDY904, which
shows that these ratios are consistent between these
two studies.Vacuole volume and surface area scaling in WT
cells
Vacuole volume and surface area were measured for yeast
cells, which were grown to log phase (Fig. 1, D and E).
Distinct scaling trends are found, such that on average,
larger cells correlate with larger vacuoles both in volume
(Pearson r ¼ 0.8, p ¼ 3  1032) and in surface area (Pear-
son r¼ 0.8, p¼ 9 1039). Qualitatively, the data from two
different strains, W303A and BY4741, agree well with each
other, indicating that as observed previously (9), size scaling
of the vacuole seems to be a conserved property.
Taking logarithmic plots of the data allows the power-law
exponent, a, to be calculated for the scaling trends. In this
Organelle Size Scaling 1989analysis, the two strains show slightly different behavior. In
the W303A strain, the vacuole surface area-cell volume
scaling exponent a ¼ 1.0 5 0.1, indicating a nearly linear
trend and a roughly constant proportionality between vacu-
ole membrane and cell size. However, the vacuole volume-
cell volume scaling exponent a ¼ 1.3 5 0.2 suggests that
the vacuole grows disproportionately larger in volume dur-
ing cell growth. For the BY4741 strain, both vacuole surface
area-cell volume (a ¼ 1.25 0.1) and vacuole volume-cell
volume (a ¼1.3 5 0.1) scaling exponents are slightly
greater than linear.
Because yeast bud asymmetrically, scaling trends can
also be measured for individual mothers and buds. Fig. 2,
A and B, show that in W303A cells, vacuole size scaling
is consistent between buds and mothers. Furthermore,
vacuole size can be normalized to cell size to give the size
scaling ratio for an individual cell. Consistent with the
observed scaling trends, total vacuole volume-cell volume
ratios increase with increasing cell size (Pearson r ¼ 0.27,
p ¼ 4  103, Fig. 2 C). Total vacuole surface area-cellFIGURE 2 Vacuole size and size ratios in W303A WT. (A) Vacuole volume
volume-to-cell size ratios and (D) Vacuole surface area-to-cell size ratios plo
(blue), individual mothers (red), and individual buds (green). In (C) and (D), li
correlation r values.volume ratios, on the other hand, do not show a significant
correlation with cell size (Pearson r ¼ 0.04, p ¼ 0.6,
Fig. 2 D), indicating that they remain constant during cell
growth, as predicted by the vacuole surface area scaling
exponent of 1.0. Vacuole surface area-cell size ratios are
also consistent when measured for buds, mothers, and
budsþmothers (total cells).
Because yeast cells can contain multiple vacuoles, total
vacuole size will depend on the number and the individual
sizes of the vacuoles. Measurements show that total vacuole
number correlates with total cell size with Pearson r ¼ 0.54
(p ¼ 4  1014, Fig. S1 A), but that average volume per
vacuole size shows a weaker correlation with Pearson
r ¼ 0.23 (p ¼ 0.005, Fig. S1 B). Vacuole shape can be eval-
uated using sphericity—based on the idea that a sphere
maximizes volume for a given surface area—which ranges
from 0 (zero volume) to 1 (perfect sphere). The average
sphericity of all individual vacuoles measured is 0.97, indi-
cating that vacuoles are generally very close to spherical
with little variation in overall shape.- and (B) Vacuole surface area-to-cell volume scaling plots. (C) Vacuole
tted against cell volume. Plots contain data for total (motherþbud) cells
nes indicate least squares linear regressions to the data with listed Pearson
Biophysical Journal 106(9) 1986–1996
FIGURE 3 Rapamycin induces larger vacuole sizes independent of auto-
phagy. (A) Yeast cells (grayscale) and vacuoles (green) growing in log
phase (left) tend to become enlarged and more fused after incubation
with 0.2 mg/mL rapamycin for 4 h (right). (B) Vacuole volume- and (C) vac-
uole surface area-to-cell size scaling trends are similar in W303A and in
atg1D and atg5D autophagy mutants. Lines indicate power-law fits to the
data, and Pearson’s r values are listed. Note that for all strains, both vacuole
volume and surface area scaling trends are increased in rapamycin-treated
cells compared to untreated cells.
1990 Chan and MarshallNormal scaling is broken in rapamycin treatment
Our ability to measure scaling relies on natural variation in
cell volume during the division cycle, but for cells growing
in log phase, the range of cell sizes is limited to a roughly
twofold range because cell division prevents individual cells
from growing very large. To see if the scaling trends hold at
larger cell sizes, we arrested cells using the drug rapamycin
that leads to an overall increase in average cell size. Rapa-
mycin is an inhibitor of TORC1, which is a master regulator
of cell growth and division. Upon incubation with the drug,
yeast cells generally complete their current cell cycle, and
then enter into an arrested state where individual cells are
still able to grow in size. This leads to an average increase
in cell size, even though the population no longer increases
in number. As has been observed in many other studies
(10,16), upon rapamycin treatment, vacuole morphology
typically becomes fused and enlarged in W303A and
BY4741 parent strains (Fig. 3 A).
This could mean that rapamycin affects vacuole size con-
trol, but it is also possible that this increase is just a reflec-
tion of the power-law relation governing vacuole-to-cell
volume scaling. In the latter case, because rapamycin in-
duces larger cell volumes, and because the observed
vacuole-cell volume scaling trend is greater than linear,
larger cells are then expected to have disproportionately
larger vacuoles. Moreover, because larger spheres have a
lower surface to volume ratio than smaller spheres, fusion
of vacuoles could be a way for the cell to accommodate
the reduced surface to volume ratio predicted by the
observed scaling relations. Thus, both the reported enlarge-
ment of the vacuole and the fusion of vacuoles seen in
rapamycin-treated cells may be a natural consequence of
scaling.
To test this possibility, vacuole size was measured in cells
that were treated with rapamycin for 4 h. Untreated cells
have an average cell size of 86 5 2 mm3, and rapamycin-
treated cells arrest and grow to a larger average size of
130 5 7 mm3 (p < 0.0001, Student’s t-test). The average
number of vacuoles per cell decreases from 2.7 5 0.1 to
1.8 5 0.2 (p < 0.0001, Student’s t-test) reflecting the ex-
pected increase in fusion, and vacuoles expand in size to
take up a greater proportion of total cell volume (ranging
from 5% to 35%). Interestingly, rapamycin-treated cells
had vacuoles that were larger both in volume (p ¼ 5 
1036, comparison of regression lines) and surface area
(p ¼ 3  1013, comparison of regression lines) when
compared to untreated cells of the same size (Fig. 3, B
and C, Table S3 a). This result indicates that the increased
vacuole size observed in rapamycin-treated cells is not
simply a product of normal scaling, but instead reflects an
alteration in the vacuole-cell size scaling relation upon rapa-
mycin treatment.
We note that although rapamycin causes vacuole surface
area to increase, it does not affect the exponent for the vac-Biophysical Journal 106(9) 1986–1996uole surface area-cell volume scaling relation, which is still
linear in rapamycin-treated cells (a ¼ 1.0 5 0.04). Rapa-
mycin only affects the prefactor slope of the scaling relation
between vacuole surface and cell volume. The robustness of
the scaling exponent to even a large perturbation in vacuole
Organelle Size Scaling 1991size by rapamycin suggests that this linear scaling may be a
fundamental aspect of size control, a point we will revisit in
the discussion below.TABLE 1 Scaling exponents for W303A, atg1D, and atg5D
strains
Volume Surface area
rap þrap rap þrap
W303A 1.35 0.2 1.55 0.1 1.0 5 0.1 1.05 0.2
atg1D 1.25 0.2 1.55 0.1 0.9 5 0.2 1.05 0.1
atg5D 1.25 0.2 1.65 0.1 1.1 5 0.1 1.15 0.1Rapamycin treatment alters scaling even in
autophagy-deficient mutants
Vacuole volume increases during rapamycin treatment are
due in part to the change in the vacuole’s fusion state—
i.e., increased fusion/decreased fission. However, a change
to the vacuole fusion state does not in and of itself explain
why vacuole surface area increases. Previous studies have
suggested that increased macroautophagy may be respon-
sible for the increase in vacuole size in rapamycin-treated
cells (16). Macroautophagy is the process by which dou-
ble-membrane autophagosomes form around cytoplasm or
organelles and fuse to the vacuole to deliver the contents
for degradation. Inhibition of TORC1 by rapamycin induces
higher levels of macroautophagy, and the increased levels of
autophagosome fusion to the vacuole could provide the
source of the increased surface area measured for rapamy-
cin-treated cells.
To test this idea, we measured the size of the vacuole in
atg1D and atg5D deletion mutants (in the W303A strain
background), which are deficient in macroautophagy. In
the absence of rapamycin, these mutants exhibit similar vac-
uole size scaling to WT cells, which indicates that vacuole
size during log growth does not depend significantly
on macroautophagy. Surprisingly, qualitative observation
found that in the presence of rapamycin, vacuoles in
atg1D and atg5D mutants appear enlarged, similar to WT.
Quantitative measurements indeed show that vacuole vol-
ume increased in these autophagy mutants in the presence
of rapamycin (atg1D: p ¼ 2  1049, atg5D: p ¼ 5 
1057, comparison of regression lines, Fig. 3 B, Table
S3 a), and that average vacuole number decreases in
atg1D from 3.25 0.1 to 1.05 0.02 (p < 0.001, Student’s
t-test) and in atg5D from 4.55 0.2 to 1.35 0.1 (p< 0.001,
Student’s t-test). As with WT vacuoles, this volume increase
during rapamycin treatment is due at least in part to the
fusion of individual vacuoles together and their subsequent
expansion. Interestingly, atg1D and atg5D also exhibit
similar increases in vacuole surface area as with the WT
in the presence of rapamycin (atg1D: p ¼ 3  1011,
atg5D: p ¼ 2  1017, comparison of regression lines,
Fig. 3 C, Table S3 b), and the scaling trends are not statisti-
cally significantly different from one another (Table S3 b).
Therefore, the rapamycin-induced growth in vacuolar mem-
brane in these mutants is similar to that seen in WT cells,
indicating that macroautophagy does not play a significant
role in the growth of the vacuole under rapamycin treatment.
The increased membrane amount in the vacuole must there-
fore be due to some other mechanism.
Using log-log plots (Fig. S2), scaling exponents were
calculated for vacuole volume- and vacuole surface area-to-cell volume trends for WT, atg1D, and atg5D strains in
the absence or presence of rapamycin (Table 1). All strains
showed an increase in volume scaling exponents to roughly
a ¼ 1.5 in the presence of rapamycin. This result is consis-
tent for vacuoles that have fused into one, roughly spherical
compartment. In contrast, all surface area scaling trends
gave scaling exponents in the range of a ¼ 0.9–1.1, again
showing that vacuole surface area maintains a linear rela-
tionship with cell size.The role of membrane trafficking in establishing
vacuole size
If autophagy is not the key regulated process by which
TORC1 signaling affects vacuole surface area scaling,
then what is? An obvious alternative candidate is membrane
trafficking, which impacts vacuole growth through fusion of
vesicles with the vacuole via anterograde pathways, and
contributes to vacuole shrinkage by budding of vesicles
from the vacuole, known as retrograde trafficking. ATG18
encodes a protein involved in binding to and regulating
the levels of phosphatidylinositols (17) in the vacuole mem-
brane, and it has been implicated in vacuole fission, which is
expected to impact the vacuole’s fusion state and therefore
volume. ATG18 is also involved in retrograde trafficking,
which removes membrane material from the vacuole and
is therefore likely to affect vacuole surface area (17,18).
The deletion atg18D gives rise to vacuole morphology phe-
notypes that qualitatively match the enlarged and fused
morphology of rapamycin-treated cells (Fig. 4 A). To ask
whether ATG18 activity might contribute to the scaling
effects seen in rapamycin treatment, we compared the vac-
uole volume-to-cell size and vacuole surface area-cell size
scaling trends in WT and atg18D (BY4741 background)
strains in the presence or absence of rapamycin. The
response to rapamycin of the vacuole in atg1D and atg5D
mutant strains was also verified in the BY4741 background
(Fig. S3).
Measurements show a significant increase in total vacuole
size scaling both in volume and in surface area in untreated
atg18D cells as compared to untreated WT cells (volume:
p ¼ 6  1033, surface area: p ¼ 7  1011, Fig. 4, B
and C, Table S3 c and d). If it was the case that inhibition
of TORC1 function by rapamycin leads to vacuole surface
area expansion by inhibiting ATG18-dependent retrograde
trafficking, we would then expect atg18D mutant cells toBiophysical Journal 106(9) 1986–1996
FIGURE 4 Retrograde and anterograde membrane trafficking affect vacuole size. Comparison of vacuole size-to-cell volume scaling trends between WT
and atg18D ((A) image, (B) volume, and (C) surface area) or betweenWTand apl5D ((D) image, (E) volume, and (F) surface area). Lines indicate power-law
fits to the data, and Pearson’s r values are listed. Without rapamycin, atg18D and apl5D show larger and smaller vacuole size scaling trends, respectively. In
the presence of rapamycin, atg18D mutants show vacuole size scaling trends similar to WT yeast, whereas apl5D vacuoles still show smaller size scaling
trends. (G) Based on these findings, we propose this interaction network in which rapamycin affects vacuole surface area primarily through effects on retro-
grade traffic and vacuole volume through effects on vacuole fusion.
1992 Chan and Marshallmimic the vacuole surface area-to-cell size scaling changes
seen in WT cells in the presence of rapamycin and atg18D
mutant cells. Indeed, there is not a significant difference be-
tween atg18D and WT þrap vacuole surface area scalings
(Fig. 4 C, p¼ 0.4, comparison of regression lines, Table
S3 d). Furthermore, addition of rapamycin to atg18D does
not significantly affect vacuole surface area-to-cell size
scaling trends (p ¼ 0.2, comparison of regression lines,
Table S3 d), which is also consistent with rapamycin lying
upstream of ATG18 in the pathway affecting vacuole mem-
brane content. Based on these results, we propose a model in
which rapamycin treatment leads to vacuole surface area
growth as a consequence of reduced ATG18-mediated
retrograde flux, rather than of increased anterograde flux
from macroautophagy upregulation (Fig. 4 G). With respect
to volume, WT –rap exhibits the smallest vacuole volume-Biophysical Journal 106(9) 1986–1996to-cell size scalings. WT þ rap, atg18D –rap, and
atg18D þrap show increased vacuole volume-to-cell size
scalings, with atg18D þrap slightly larger than the other
two (Table S3 c). Again, these changes in vacuole volume
result from increased vacuole fusion and expansion.
Given the notable effect of inhibiting retrograde traffic on
increasing vacuole size scaling, we hypothesized that inhibi-
tion of anterograde trafficking, i.e., trafficking of vesicles
from the Golgi to the vacuole, should have a complementary
effect and lead to vacuole size decreases. We tested this
using the apl5D deletion mutant in the BY4741 background,
which blocks the alkaline phosphatase delivery pathway,
which is thought to deliver vesicles directly from the Golgi
to the vacuole (19). The apl5D deletion has not been re-
ported to exhibit an obvious vacuole size or morphology
phenotype, at least based on visual inspection (Fig. 4 D).
Organelle Size Scaling 1993However, when we performed quantitative measurements
we found that apl5D vacuoles indeed have reduced vacuole
volume- and vacuole surface area-to-cell volume scalings
compared to WT (p¼ 7 1015 and p¼ 9 1010, respec-
tively, comparison of regression lines, Fig. 4, E and F, Table
S3 c and d). In the presence of rapamycin, vacuoles in apl5D
cells do expand and grow into larger sizes (p ¼ 2  1036,
comparison of regression lines, Table S3 c and d), but
their volume and surface area scaling trends are reduced
compared to WT cells treated with rapamycin (p ¼ 2 
104 and p ¼ 0.002, respectively, comparison of regression
lines, Table S3 d). Therefore, blocking APL5-dependent
anterograde trafficking leads to overall decreases in vacuole
volume and surface area; both in the presence and absence
of rapamycin.
Scaling exponents were also calculated for BY4741
parent, atg18D, and apl5D strains (Table 2 and Fig. S4).
Measured vacuole surface area-to-cell volume scaling expo-
nents ranged from a ¼ 1.1–1.5, and were generally less
sensitive to rapamycin treatment, which could indicate a
conserved feature of vacuole morphology. Our analysis indi-
cates that in the absence of rapamycin, BY4741WTexhibits
a nonlinear scaling with the power-law exponent a ¼ 1.2,
and that atg18D has a ¼ 1.4. These values stand in contrast
to the consistently linear scaling values observed for
W303A background strains. Although these differences
are not yet fully understood, we find empirically that if
smaller cells are excluded from consideration for BY4741
or atg18D, values for a become closer to linear. Because
smaller cells tend to be newborn mothers, the differences
in scaling for these strains may in part reflect differences
in inheritance during budding from their own mothers. For
example, delayed inheritance might lead new cells to
initially contain disproportionately smaller vacuoles, at
which point other mechanisms (discussed in the next sec-
tion) would begin to control the vacuole-to-cell size scaling.
Such a scenario could account for the observed nonlinear
scaling relationships observed in the BY4741 background.Models for establishing vacuole size scaling
The strong scaling trend between vacuole size and cell size
raises the question of how this scaling is achieved, andTABLE 2 Scaling exponents for BY4741, atg18D, and apl5D
strains
Volume Surface area
rap þrap rap þrap
BY4741 1.3 5 0.1 1.8 5 0.1 1.25 0.1 1.35 0.1
atg18D 2.0 5 0.1 2.1 5 0.1 1.55 0.1 1.45 0.1
apl5D 1.3 5 0.1 1.9 5 0.1 1.15 0.1 1.45 0.04
Entries are the slope and the standard error of the slope of the linear regres-
sion to the log-log plots of measured cell and vacuole sizes. The vacuole-to-
cell volume scaling exponents increased with rapamycin treatment in
BY4741 and apl5D (but not in atg18D) due to vacuole fusion.particularly the question of whether or not the cell needs
to actively measure the size of its vacuole and use a feed-
back loop to adjust the vacuoles to a size appropriate to
the cell size. Is there any way to have scaling without
such feedback? Vacuoles are dynamic organelles, and their
volume and surface area are governed by competitive pro-
cesses of growth and shrinkage, including both homotypic
fusion/fission among vacuoles or anterograde/retrograde
trafficking between vacuoles and other membrane compart-
ments. Vacuoles do not show a constant absolute size, but
rather a defined scaling with respect to cell size. Thus, a
quantitative model of vacuole size control needs to explain
how this scaling is achieved through the regulation of
growth and shrinkage.
Here, we attempt to consider the simplest possible model
for vacuole size scaling consistent with our data, and ask how
much regulatory complexity is required to achieve scaling of
the type that we have observed. We begin with the general
power law expression of vacuole-to-cell size scaling:
V ¼ ACa; (1)
where V and C represent vacuole and cell size, respectively,
A is the scaling prefactor, and a the scaling exponent. The
relationship between vacuole and cell growth rates, dV/dt
and dC/dt, can be found by differentiation of Eq. 1 (using
the chain rule):
dV=dt ¼ ðdV=dCÞðdC=dtÞ ¼ AaCða1ÞðdC=dtÞ: (2)
In general, then, vacuole growth can be written as a function
of both cell size and cell growth rate.
We consider the special case when a approaches 1—i.e.,
linear scaling—then C(a-1) also approaches 1. Replacing
dV/dt and dC/dt with ratev and ratec, each of which can
potentially be a function of instantaneous cell size, Eq. 2
then reduces to
ratev ¼ A  ratec: (3)
Given that vacuole surface area-to-cell volume scaling
seems to show linear or near-linear scaling in the W303A
background strains, we will focus specifically on vacuole
surface growth. In the membrane trafficking model, net
vacuole growth depends on a forward (anterograde, þ)
and a reverse (retrograde, ) rate:
ratev ¼ rateþ  rate ¼ A  ratec: (4)
Solving for rateþ (or rate) gives a function of rate
(or rateþ) and ratec. This general result indicates that a
linear vacuole surface area-to-cell size scaling would con-
strain the possible relations between trafficking rates and
cell growth rates.
Going further in this analysis, one straightforward case in
which Eq. 4 holds true is when rateþ and rate are both pro-
portional to ratec with constants kþ and k, soBiophysical Journal 106(9) 1986–1996
1994 Chan and Marshallratev ¼ A  ratec ¼ kþratec  kratec: (5)
With linear scaling, the slope of the scaling trend reflects the
ratio between vacuole and cell growth. Thus, if there is pro-
portionality among anterograde and retrograde trafficking
rates and cell growth rates, then scaling will arise as an
inherent consequence. Although this may occur coinciden-
tally, such a scenario may also indicate coordination be-
tween cell growth rates and trafficking rates, which could
be achieved if, for example, cell growth and vacuole growth
both were rate-limited by the same cellular process such as
biosynthesis or nutrient uptake.
In the limiting case of linear cell growth, which has been
found for certain cell types (20,21), ratec is constant, which
would imply by Eq. 4 that ratev is also constant. Linear
scaling would then arise if vacuole growth and shrinkage
rates are held relatively constant, and such a scenario would
not require any direct regulatory linkages between cell
growth and vacuole growth. It is thus possible to achieve
linear scaling of vacuole surface area to cell volume in a
quite simple way if both rates are constant and independent
of cell size.
From Eq. 2, scaling exponents other than a ¼ 1, as seen
for vacuole volume-to-cell size measurements, indicate
some other relationship of vacuole growth with cell size
and growth rate. As noted in the discussion, the total volume
of the vacuole in the cell will depend largely on its fusion
state, i.e., the number of vacuoles in a cell. Because this
number correlates with cell size (Fig. S1 A), that contributes
to the overall vacuole volume-to-cell size scaling. It will
therefore be interesting to study how vacuole fusion and
fission rates relate to cell growth rates.
Another consideration is that in the asymmetrically
budding yeast, vacuoles are distributed between mother
and bud compartments such that both show similar scaling
trends to the total cell. This trend stands in marked contrast
to mitochondria, whose density in buds increases with bud
cell size, plateauing after a certain bud cell size threshold,
whereas mitochondrial density in the mother decreases
with mother cell size (7). That vacuole size scaling is
more consistent between compartments may indicate impor-
tant differences in strategies for regulation of the size of the
two organelle systems. Vacuole distribution between the
larger mother and smaller bud depends on the localization
of vacuole biogenesis and the employment of inheritance
mechanisms (22). Future studies will use mutations in inher-
itance mechanisms to dissect their contributions to vacuole
size control.
Furthermore, to better understand whether there is
coupling between vacuole and cell growth, and how biogen-
esis and inheritance contribute to vacuole size control; it
will also be useful to use time-resolved measurements and
analysis to determine how rates of growth are correlated,
and how they respond to perturbation. Such experiments
would determine whether vacuole size is actively regulatedBiophysical Journal 106(9) 1986–1996to maintain the observed scaling ratio, and the precision of
this regulation would give rise to the noise in the measured
vacuole-to-cell size scaling plots.DISCUSSION
Scaling provides a powerful context for discovering and
understanding the mechanisms of organelle size control
(3,4,8). Using the computational algorithm described, quan-
titative measurements of vacuole lumenal volume and mem-
brane surface area have revealed that both exhibit scaling
with respect to cell size—i.e., larger cells tend to contain
larger vacuoles. In W303A yeast, vacuole membrane con-
tent stays in proportion with overall cell volume, and the
vacuole surface area-to-cell size ratio remains constant
over all sizes measured and between mother and bud cells.
Though our analysis measures total cell volume, it may
also be that organelle size responds to cytoplasmic volume.
Interestingly, increasing evidence suggests that total organ-
elle volume scales with cell volume, in which case cyto-
plasmic volume would be a constant proportion of total
cell volume.
Vacuole size can impact function in a number of ways.
The lumenal volume is likely to affect the capacity of the
organelle to carry out its degradative and storage functions.
In addition, vacuole size determines its ability to respond to
osmotic and toxin stress. Thus, the cell may maintain a vac-
uole at a size appropriate to perform these functions, but not
too large as to waste energy or material.
Previous genetic screens have established that membrane
trafficking pathways play important roles in establishing
vacuole morphology (11), and it has been proposed that
the flux of membrane to and from the vacuole via these path-
ways will determine how much limiting membrane and
therefore surface area is available to the organelle (23).
Measurements of vacuole size scaling for the apl5D and
atg18D deletion mutants strongly support these models.
The former illustrates that perturbations in anterograde traf-
ficking lead to marked decreases in vacuole surface area-to-
cell size scaling trends, presumably from the decreased
delivery of membrane material to the vacuole. The latter
provides evidence that blocking retrograde trafficking leads
to increases in vacuole size scaling.
In rapamycin-treated cells, both vacuole volume and sur-
face area increase to sizes greater than those predicted by
WT scaling trends for the increased cell sizes. Rather,
vacuole-to-cell size scaling has been altered by the drug
treatment. The increase in autophagy represents a logical
source for increased anterograde traffic and vacuole mem-
brane, but the similar increases in size in autophagy-
deficient mutants’ atg1D and atg5D show that increased
delivery of autophagosomes to the vacuole is not necessary
to give the observed increases in vacuole surface area.
Rapamycin-treated cells and atg18D mutants show similar
vacuole surface area-to-cell volume scalings, and rapamycin
Organelle Size Scaling 1995treatment fails to increase vacuole size in atg18D, suggest-
ing that TORC1 and ATG18 may act in the same pathway
affecting vacuole membrane content. It remains unclear
how rapamycin influences anterograde trafficking, given
that Atg18p has not been shown to be a substrate of
TORC1. Another possibility involves vacuole lipid compo-
sition. Other proteins such as Fab1p and Vac14p interact
physically and functionally with Atg18p in regulating
PI(3,5)P2 levels in the vacuole, and mutants in these genes
also lead to vacuole enlargement similar to that observed
for atg18D (24).
Interestingly, scaling plots for cells in log-phase show that
the volume of the vacuole increases disproportionately with
cell growth, even though in principle it is possible to achieve
a linear vacuole-cell volume scaling using the volume con-
trol mechanisms described below. Because cell division pre-
vents cells from growing too large, it may be that the cell
does not generally enter the size regimes in which dispro-
portionate vacuole volume growth becomes problematic. It
will be interesting to explore whether these trends hold
under other conditions, which perturb cell size to a greater
extent, such as cell cycle blocks.
With a given surface area, the maximal lumenal volume is
achieved if the vacuole is a single spherical compartment.
The vacuole can achieve any volume less than this
maximum in two main ways. One is to fragment the vacuole
into multiple compartments, which is observed in the major-
ity of log-phase cells. Fragmentation state will depend
primarily on the equilibrium between fusion and fission,
which has been the focus of much previous research
(10,25). Indeed, the increase in vacuole volume in rapamy-
cin-treated cells and atg18D mutants has been linked to
increased fusion and decreased fission rates, respectively
(10,17). To increase in volume after fusion, the vacuole
must expand, which likely involves the transport of water,
ions, and other species across the vacuole membrane. This
inflation is driven in part by the high osmotic pressure inside
the vacuole. Conversely, the fragmentation of a single spher-
ical vacuole into multiple ones would necessitate a loss of
volume, which would require some energy input to either
constrict the membrane or for lumenal efflux.
Volume can also be adjusted by changes to vacuole shape.
Although nonspherical vacuoles are observed, they seem
largely restricted to transient segregation structures ob-
served during cell division. Though individual vacuoles
can themselves exhibit any shape, they typically are also
roughly spherical. The shape of vacuoles has been shown
to be due to the high osmotic pressure inside the vacuole,
as shifting the cell to hypertonic conditions leads to invagi-
nations, fragmentation, and other alterations in vacuole
shape (26).
Total vacuole size can increase either by proliferating the
number of vacuoles or by increasing the size of individual
vacuoles. In budding yeast, the correlation of vacuole num-
ber to cell size suggests that the former mechanism contrib-utes strongly to vacuole growth. Proliferation of similar
sized vacuoles would tend to preserve the vacuole’s surface
area-to-volume ratio, in contrast to the scenario where num-
ber is kept constant and individual vacuoles grow, which
would decrease this ratio, and this may favor proliferation
as the vacuole’s growth strategy. Fig. S1 C shows the vacu-
ole surface area-to-volume ratio tends to plateau at higher
cell sizes at a value higher than the expected value for a sin-
gle spherical vacuole with the equivalent volume. In other
plant and fungal cells, the expansion of vacuoles can drive
cell expansion, and it will be interesting to study how
scaling is established in such systems (27–29).CONCLUSION
The results of our quantitative studies of the yeast vacuole
illustrate the fundamental questions and concepts that can
be addressed using quantitative measurements of organelle
size scaling. The linear scaling trends measured in this study
suggest a particularly simple way to explain scaling based
on vacuole growth proportionality to cell growth, and indi-
cate that the mechanisms of size regulation will need to
be explored further using time-resolved analysis of organ-
elle and cell growth to test whether and how vacuole and
cell growth are coordinated, and whether there is active
feedback to ensure proper organelle size.SUPPORTING MATERIAL
Four figures and three tables are available at http://www.biophysj.org/
biophysj/supplemental/S0006-3495(14)00290-2.REFERENCES
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